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ABSTRACT: Multiple publications have reported the use of coyotes (Canis latrans) in animal-
based surveillance efforts for the detection of Yersinia pestis. Coyotes are likely exposed via flea
bite or oral routes and are presumed to be resistant to the development of clinical disease. These
historic data have only been useful for the evaluation of the geographic distribution of Y. pestis in
the landscape. Because the canid immunologic response to Y. pestis has not been thoroughly
characterized, we conducted experimental inoculation of captive-reared, juvenile coyotes (n58)
with Y. pestis CO92 via oral or intradermal routes. We measured the humoral response to Y. pestis
fraction 1 capsular protein (anti-F1) and found a significant difference between inoculation groups
in magnitude and duration of antibody production. The anti-F1 titers in animals exposed
intradermally peaked at day 10 postinoculation (PI; range51:32 to 1:128) with titers remaining
stable at 1:32 through week 12. In contrast, orally inoculated animals developed higher titers
(range51:256 to 1:1,024) that remained stable at 1:256 to 1:512 through week 6. No clinical signs
of disease were observed, and minimal changes were noted in body temperature, white blood cell
counts, and acute phase proteins during the 7 days PI. Gross pathology was unremarkable, and
minimal changes were noted in histopathology at days 3 and 7 PI. Rechallenge at 14 wk PI via
similar dosage and routes resulted in marked differences in antibody response between groups.
Animals in the orally inoculated group produced a striking increase in anti-F1 titers (up to 1:4,096)
within 3 days, whereas there was minimal to no increase in antibody response in the intradermal
group. Information gathered from this experimental trial may provide additional insight into the
spatial and temporal evaluation of coyote plague serology.
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INTRODUCTION
Plague (Yersinia pestis) is a flea-borne
disease that continues to have endemic
foci throughout the world. Human infec-
tion with this zoonotic disease is highly
dependent on peridomestic exposure to
infected animals or the fleas that infest
them (e.g., Christie et al., 1980; Gage et al.,
2000; Gould et al., 2008). Although plague
is generally maintained in a sylvatic cycle
between rodent species and their associ-
ated fleas, it can spill over and infect a
variety of wild and domestic animals.
There are substantial differences among
species in their susceptibility to the
disease manifestations of Y. pestis infec-
tion. For example, infection is highly lethal
in prairie dogs (Cynomys spp.) and black-
footed ferrets (Mustela nigripes) and
moderately virulent in cats (Felis catus;
Rust et al., 1971), whereas canids (Canis
spp.) are considered refractory (Rust et al.,
1971) but can act as a source for disease
transmission (Poland et al., 1973; Wang
et al., 2011).
In recent years, coyotes (Canis latrans)
and red foxes (Vulpes vulpes) have in-
creased in number in urban environments
of North America. These rodent hunters
can acquire Y. pestis infection through the
bite of infected rodent fleas or through
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ingestion of infected rodents. Although
there is no evidence of antemortem
transmission from these canids, there are
historic reports in which coyote carcasses
have been linked to human plague cases
(Poland et al., 1973; von Reyn et al., 1976).
There is a clear potential for nondomestic
canids to transfer infected fleas over
significant distances (Mcgee et al., 2006;
Boone et al., 2009) as compared with
peridomestic rodents. Additionally, the
increase in urbanization of wildlife en-
hances the risk of disease transmission to
domestic dogs and cats, which, in turn,
could result in increased exposure and
disease in human populations (Gage et al.,
2000; Gould et al., 2008).
Canids often survive infection with Y.
pestis and produce detectable and specific
antibody responses. They are, thus, con-
sidered useful sentinels of disease, and
many animal-based surveillance programs
conducted during the past century have
been based on serologic data obtained from
wild coyotes (e.g., Salkeld et al., 2006;
Brinkerhoff et al., 2009). However, the
mechanism of their infection, its frequency
and timing, and the duration of an antibody
response in these natural settings are
difficult to measure. We seek to better
describe the serologic and clinical respons-
es of coyotes following controlled routes of
oral and intradermal (ID) infection with Y.
pestis. These data provide a baseline
characterization for better understanding
surveillance data in coyotes.
MATERIAL AND METHODS
Experimental animals
Juvenile, captive-reared coyotes (n512; US
Department of Agriculture–Animal and Plant
Health Inspection Services [USDA-APHIS],
Wildlife Services, Predator Field Station,
Millville, Utah, USA) obtained at approximate-
ly 4 mo of age were housed in animal biosafety
level 3 isolation at the Animal Disease
Laboratory (Colorado State University, Fort
Collins, Colorado, USA). Before transfer, coy-
otes were vaccinated with standard canine
vaccines (VanguardHPlus5/CV and DefensorH3;
Pfizer Animal Health, New York, New York,
USA). Animals were housed individually in
standard, elevated dog runs (1.2 m32.1 m;
2.6 m2), four runs per room, each with a
manufactured polyvinyl chloride (PVC) den box
(53 cm diameter356 cm height). Animals were
provided water and commercial dry dog food ad
libitum, supplemented with dead mice, peanut
butter, eggs, fruit, rawhide, long bones, or pig
ears as daily environmental enrichment. Clinical
evaluations were made twice daily on each
animal throughout the study to detect changes
in behavior, food consumption, fecal output,
and activity level. At approximately 5 mo of age,
temperature recorders (Thermochron iButtonH,
Maxim Integrated Products, Inc., Sunnyvale,
California, USA) were surgically implanted into
the peritoneal cavity of all coyotes via a caudal
left flank incision. All coyotes were treated with
topical selamectin (RevolutionH, Pfizer Animal
Health, Madison, New Jersey, USA) at 6 mg/kg
approximately 4 wk before inoculation. Coyotes
used in the inoculation trials were stratified by
litter (three litters) and then randomized into
two inoculation groups. One animal from each
inoculation group was humanely euthanized on
day 3 and day 7 postinoculation (PI) to assess
gross and microscopic lesions during early
infection; all others were euthanized at the
termination of the study. Control animals
(n52) were age-matched but maintained at
the captive breeding facility in outdoor pens
and euthanized at the termination of the study.
The tissues collected during postmortem ex-
amination included all major internal organs
(liver, lung, spleen, heart, kidney, and adrenal
glands) and lymphoid tissues, including pala-
tine tonsil, retropharyngeal lymph nodes
(RPLN), submandibular lymph nodes
(SMLN), bronchiolar or tracheal lymph nodes,
and mediastinal, prescapular, axillary, popliteal,
and mesenteric lymph nodes. Tissues were
fixed in 10% neutral-buffered formalin for
histologic examination or stored frozen at
280 C until further analysis. Histopathology
descriptions are based on routine H&E staining
and Y. pestis–specific immunohistochemistry
(IHC; Guarner et al., 2002).
Yersinia pestis challenges
At approximately 6 mo of age, six animals
were inoculated by ID injection (50 mL)
bilaterally in the prescapular region with a
target dose of 103 colony-forming units (cfu) Y.
pestis CO92. Bacteria for the inoculum were
cultivated from frozen stock, grown in brain
heart infusion (BHI) broth at 28 C for 48 hr,
and diluted in phosphate-buffered saline to
the desired concentration. The dose inoculat-
ed was determined by back titration of the
BAETEN ET AL.—EXPERIMENTAL INOCULATION OF COYOTES WITH YERSINIA PESTIS 933
inoculum on BHI agar plates. The other six
coyotes were offered one to three Y. pestis–
infected mice for consumption. These 6-wk-
old imprinting control region (ICR) mice were
inoculated subcutaneously (SC) with 102 cfu of
Y. pestis CO92 (50% lethal dose [LD50] of
approximately 20) in a 0.1-mL volume, and
mice were euthanized by cervical dislocation
once moribund (approximately 48 hr PI). At
14 wk PI, four coyotes from each inoculation
group were rechallenged with Y. pestis using
the same route and dosage as the original
challenge. The coyotes were manually or
chemically restrained for serial venous blood
sample collection in gel serum separation and
ethylenediaminetetraacetic acid tubes (Vacu-
tainerH, Becton Dickson, Franklin Lakes, New
Jersey, USA). Complete blood cell counts
were performed with an automated hematol-
ogy analyzer (HemaTrue Hematology Analyz-
er, Heska, Des Moines, Iowa, USA). Whole
blood and selected tissues were cultured for Y.
pestis using standard techniques (Chu, 2000).
Briefly, whole blood was plated directly or
diluted 1:5, and tissues (organs51 g; lymph
nodes50.5 g) were manually homogenized in
1 mL of BHI broth followed by plating. Feces
were cultured after 24 hr enrichment in
buffered-peptone water. All samples were
plated to the selective and differential media;
cefsulodin-irgasan-novobiocin agar (Becton
Dickinson) and incubated at 37 C with 5%
CO2 for $72 hr. Isolates were confirmed as Y.
pestis based on characteristic colony morphol-
ogy and Gram stain; biochemical confirmation
was performed using Micro-IDH (Thermo
Fisher Scientific, Lenexa, Kansas, USA).
Serology
Serum was harvested, heat inactivated at
56 C for 30 min, and stored at 280 C before
analysis. Titers of antibody reactivity to Y. pestis
fraction 1 capsular protein (anti-F1) were
determined by passive hemagglutination as
previously described (Chu, 2000). C-reactive
protein (CRP) and serum amyloid A (SAA)
values were determined by enzyme-linked
immunoassay (ELISA) (PHASETM Canine
CRP assay and PHASETM Serum Amyloid A
multispecies assay, Tridelta Development Lim-
ited, Maynooth, Kildare, Ireland) according to
manufacturer specifications.
Statistical analysis was performed using SAS
9.2 (SAS Institute, Cary, North Carolina, USA).
Repeated-measures analysis of variance was
used to determine differences among and
between groups by means of Proc Mixed
procedures. Unless otherwise noted, P-values
of,0.05 were considered statistically significant.
RESULTS
All animals used in this study were
antibody negative (anti-F1 titers,1:4)
before inoculation with Y. pestis. No
mortality occurred, and no appreciable
signs of morbidity were noted during daily
observations of the 12 coyotes PI. Food
consumption and activity levels of the
coyotes did not change from baseline
observations throughout the study. Yer-
sinia pestis was not isolated from blood
cultures or feces collected between day 0
and day 7 PI. Complete blood cell counts
were normal (Gates and Goering, 1976),
except white blood cell counts (WBCs),
which peaked at a mean (range) of
21.03103/L (20.5–21.53103/mL) on day 2
PI in the group inoculated orally. Increas-
es in WBCs were attributed to increases in
absolute and percentage of granulocyte
counts only.
Intra-abdominal body temperatures, as
measured by iButtons, were recorded for
each animal at 1- or 3-hr intervals through-
out the study. Broad circadian rhythm
variations were noted with preinoculation
temperatures recorded between 36.1–
39.9 C. High body temperatures were
noted during high-stress conditions, such
as manual restraint and husbandry manip-
ulations. All these factors made assessment
of febrile conditions in the coyotes difficult.
However, comparison of PI average daily
body temperatures compared with mean
preinoculation values demonstrated a 0.6 C
(0.3–0.9 C) increase on day 1 and 0.3 C
(0.1–0.6 C) on day 2 PI for animals in the
oral group. Although statistically signifi-
cant (P,0.0001 and P50.02, respectively),
the clinical relevance is arguable. No
statistical difference was noted in body
temperatures taken from animals in the ID
group between 1 and 7 days PI.
To assess the activation of the innate
immune response, the acute phase pro-
teins CRP and SAA were measured at 0, 2,
3, 5, and 10 days PI. The CRP and SAA
were found to be markedly elevated from
baseline in all of the animals in the group
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exposed by ingestion. The highest CRP
levels (.120 ng/mL) were noted on days
2 and 3 PI, with significant declines on
day 5 and approaching baseline by day 10
PI. The SAA levels were .160 ng/mL on
days 2 and 3 PI but were undetectable on
days 0, 5, and 10. Slight increases in CRP
above baseline (10–25 ng/mL) were
detected in three of the six animals in
the ID exposure group; however, SAA
was not detected in this group at any time
point.
Gross pathology was unremarkable on
animals sacrificed at days 3 and 7 PI from
each group. Lesions were not observed at
ID inoculation sites. Superficial lymph
nodes were not palpable. No gross lesions
were noted in internal organs, and Y.
pestis was not isolated from internal organ
(spleen, liver, heart, kidney, and adrenal
glands) homogenates. Of all of the lym-
phoid tissues examined, the palatine
tonsils, SMLN and RPLN lymph nodes
were slightly edematous on day 3 PI in the
coyote that was inoculated by ingestion.
However, Y. pestis was not isolated from
any of the lymphoid tissues cultured,
including palatine tonsils, RPLNs,
SMLNs, and bronchiolar or tracheal,
mediastinal, prescapular, axillary, poplite-
al, and mesenteric lymph nodes.
Histologic abnormalities were noted in
the spleen, liver, lung, and cervical lymph
nodes in the animals inoculated by
ingestion. Mild lymphoid depletion was
noted in the spleen of the day-3 animal
inoculated by ingestion, and mild spleni-
tis was noted in the day-7 animal. Mild
hydropic degeneration of the central
lobular regions of the liver was noted in
the day-3 animal inoculated by ingestion.
The lungs had small areas of focal,
interstitial thickening in both animals.
However, Y. pestis was not detected by
IHC in lung tissues. Mild lymphoid
hyperplasia with suppurative tonsillitis
and mild suppurative lymphadenitis was
noted in the palatine tonsil and SMLN of
the day-3 animal inoculated orally. Com-
pression of the subcapsular sinusoids was
noted in the RPLN and SMLN of the
day-7, orally inoculated animal. The
other lymph nodes were described as
reactive or quiescently active (tracheal/
bronchial, prescapular, axillary, popliteal,
and mesenteric) and did not differ in
presentation from that of the control
animals.
Histologic changes were less pro-
nounced in the animals inoculated ID. A
mild splenitis was noted in the day-3
animal. Focal, alveolar, interstitial thick-
ening was present in both the day-3 and
day-7 animals but were negative for Y.
pestis by IHC. The lymphoid tissue in the
ID-inoculated animals were similar to
those of the controls, except for the
SMLN of the day-3 animal, which had
focal areas of compression of the subcap-
sular sinusoids, but no significant accu-
mulation of neutrophils was noted.
There were major differences in the
magnitude of antibody responses between
inoculation groups. Anti-F1 titers for
animals in the ID exposure group had
already reached their maximum levels by
day 10 PI, ranging from 1:32 to 1:128
(Fig. 1). These antibody titers remained
stable with a group median titer of 1:32
through wk 14 PI. In contrast, the orally
inoculated animals had higher anti-F1
titers (1:256 to 1:1,024) that remained
stable at 1:256 or 1:512 through wk 6.
Between wk 6 and 14, there was a twofold
decline in titers (Fig. 2).
Marked differences in antibody produc-
tion were again noted between groups
after rechallenge. Animals in the group
exposed by ingestion produced a striking
increase in anti-F1 titer of up to 1:4,096
within 7 days after rechallenge, and those
antibody titers remained elevated for the
next 4 wk (Fig. 2). In contrast, there was
minimal to no increase in antibody re-
sponse noted over 4 wk in the animals
reinoculated by the ID route (Fig. 1). To
further investigate the lack of an anam-
nestic response, the animals in the ID
group were rechallenged a second time
(4 wk after initial rechallenge) and again,
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there was no change in anti-F1 titers over
2 additional wk (Fig. 1).
DISCUSSION
The serologic response to F1 capsule
antigen in coyotes exposed by ingestion
was similar to that described in previous
studies using canids. Domestic dogs (Ca-
nis lupus familiaris) offered Y. pestis–
infected rat viscera showed peak geomet-
ric mean titers (GMT) of 1:2,048 at day 10,
which gradually declined to 1:256 by day
90 and subsequently remained stable
through day 330 (Rust et al., 1971). In
another study, a number of wild carni-
vores, including coyotes, were orally inoc-
ulated with Y. pestis, but inoculation dose
and antibody titers were not reported,
making it difficult to compare to other
studies. Nonetheless, the timing of the
antibody response reported was similar,
with first detection at 8–14 days and a
peak in titers between 20 days and 30 days
that later declined to undetectable levels
by 6–8 mo (Barnes, 1982).
Previously reported trials using oral
inoculation have demonstrated that the
probable route of entry for Y. pestis is via
palatine tonsil/pharyngeal exposure (Rust
et al., 1972; Chen et al., 1976; Butler et al.,
1982). In our study, individual variation in
consumption of infectious material was
observed; some mice were fully consumed
whereas others were mouthed or partially
ingested, and we speculate that some of
the variability in antibody titer within the
group may be due to differences in the
dose and exposure to Y. pestis within the
oral cavity. These results are similar to
those presented for oral infection in swine
(Sus scrofa) (Marshall et al., 1972) and
raccoons (Procyon lotor) (Shepherd,
1973). This variable dose exposure may
also explain the differences noted in
antibody response between the coyotes
in this study and the dogs infected via
ingestion of infected rat viscera (Rust et
al., 1971).
The low dose of organism inoculated ID
in our study was designed to approximate
a dose delivered by a single flea bite, and
the amplitude of antibody production
noted in these animals differed somewhat
from previous studies. These differences
were likely due to variations in route of
exposure and dose of inoculum. Two dogs
inoculated with Y. pestis SC at 103 or 107
cfu had reported peak GMT of 1:1,024,
which persisted at 1:128 thru day 330
FIGURE 2. Geometric mean titers as measured
by passive hemagglutination against Yersinia pestis
F1 antigen for coyotes (Canis latrans) exposed orally
to Y. pestis. Error bars represent the range of
antibody titers for coyotes (n54) in this group. The
arrow designates rechallenge at 98 days postinfection.
FIGURE 1. Geometric mean titers as measured
by passive hemagglutination against Yersinia pestis
F1 antigen for coyotes (Canis latrans) exposed
intradermally to Y. pestis. Error bars represent the
range of antibody titers for coyotes (n54) in this
group. The arrow designates rechallenge at 98 days
postinfection. The star designates a second rechal-
lenge at 126 days postinfection.
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(Rust et al., 1971); further comparison to
this study is limited because individual
titers were not available. Domestic ferrets
(Mustela putorius furo) inoculated SC
with #103 organisms failed to produce
an antibody response to F1 (Williams et
al., 1991). Likewise, a raccoon inoculated
ID with 104 organisms produced a peak
antibody titer of only 1:16 (Shepherd,
1973), and multiple rat (Rattus) species
inoculated SC with serial dilutions of Y.
pestis (102 to 107 cfu) failed to produce a
consistent antibody response at doses
,104 cfu. In addition, rats in the same
study lacked an anamnestic response after
low-dose rechallenge, but mounted a
significant antibody response with subse-
quent moderate- to high-dose rechalleng-
es (Chen and Meyer, 1974).
In the present study, the ID route was
chosen to mimic natural exposure via flea
bite. Previous experimental inoculation
studies used the SC route rather than an
ID route, and little is known about the
difference in pathogenesis or antigen
presentation between exposure routes.
The dose administered was similar to that
reported in the literature for flea trans-
mission (Jarrett et al., 2004; Lorange et al.,
2005); however, the inoculum did not
contain components of flea saliva which
may have immunomodulatory effects (An-
dersen et al., 2007; Vadyvaloo et al., 2010).
Recent microarray analyses compared the
transcriptome of Y. pestis recovered from
infected fleas with that of the organism
grown in culture or recovered from
infected rat lymph nodes. Differences in
gene upregulation suggest that bacterial
growth within the flea midgut results in
characteristics that are different than in
vitro cultures and in vivo propagation
(Vadyvaloo et al., 2010). This is further
characterized by the observation that a
decrease in phagocytosis of Y. pestis by
murine macrophages and human neutro-
phils was noted after passage through a
flea. These findings suggest that the flea
midgut environment may prepare Y. pestis
for its exposure to, and evasion of, the
mammalian innate immune response (Jar-
rett et al., 2004; Vadyvaloo et al., 2010).
The substantial variation in antibody
titers noted between oral and ID inocula-
tion groups is likely a reflection not only of
route of exposure but also of differences in
dose, and possibly Y. pestis characteristics
related to cultivation (i.e., 28 C vs. 37 C).
The inoculum used for ID exposure was
grown at 28 C, and therefore, it is
reasonable to assume that Y. pestis was
presented to the immune system with
hexa-acylated lipopolysaccharide, which
likely triggers the TLR4 response and
induces a localized proinflammatory re-
sponse, both of which might result in the
rapid clearance of the organism by an
efficient, localized, innate immune re-
sponse. To investigate the extent to which
the lack of response in the ID group was
dose related, animals in this group were
rechallenged a third time; two animals
were inoculated ID with 104 cfu and two
animals were offered infected mice (data
not shown). Those receiving a fourth ID
inoculation at 104 cfu (approximating 10–
20 flea bites), demonstrated a 10–20-fold
titer increase, with peak titers reaching
1:512 and 1:1,024. Even more pro-
nounced, but in keeping with high re-
sponses to oral inoculation, the two
animals receiving a final oral exposure
reached titers of 1:8,192 and 1:16,384
respectively. These findings do not specif-
ically address effects of inoculation route
but strongly suggest a dose-dependent
antibody response.
The minimal change in histology, anti-
body titers, and acute phase proteins,
suggests that the ID inoculation used in
this study resulted in a localized proin-
flammatory response. It is suspected that
Y. pestis experienced rapid local clearance
by phagocytes within the dermis. Although
antigen presentation did occur as noted by
the production of anti-F1 antibody, Y.
pestis was not recovered by culture or
visualized in regional lymph nodes. Per-
sistence of Y. pestis inoculated by naturally
infected fleas in the dermis and its
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associated evasion of the innate immune
response may result in production of
higher antibody titers.
Limitations of this study include lack of
data to assess duration of antibody titers
over multiple seasons. The assumption is
that in endemic areas coyotes will have
continued exposures throughout a season
which is why emphasis was placed on
rechallenge antibody titer measurements
rather than duration of antibody persis-
tence. This study had a small sample size
per group, which included mostly males.
Previous serologic assessments to Y. pestis
in rodents and coyotes indicate that there
may be differences in the level and
duration of antibody production between
sexes (Willeberg et al., 1979; Jones et al.,
2000). Based on our results, further
characterization of the potential effects
of dose and flea-induced changes to Y.
pestis on antibody production may be
warranted. Nonetheless, our data provide
a baseline from which to interpret serolog-
ic titers collected from free-ranging coyotes.
These data may be helpful in refining the
current epidemiologic models that use
coyote serosurveillance data to predict
human risk in plague-endemic areas (Low-
ell et al., 2009; Brown et al., 2011). High
antibody titers should indicate that expo-
sure to Y. pestis is likely recent or recurrent.
However, further evaluation is necessary in
the interpretation of low to moderate
antibody titers to differentiate waning titers
from low-dose exposures. In addition, these
results suggest that the use of a standard
fourfold or greater titer change between
acute and convalescent titers to confirm
canid Y. pestis infection may not be
clinically sound. It is possible that isotype
analysis of anti-F1 antibodies will enable
better determinations of acute, convales-
cent, and distant-past infections in sentinel
coyotes and better assessment of disease
occurrence and associated human risk.
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